Supramolecular arrangements in human amyloid tissues using SAXS

Area of Science:

• Biophysics
• Materials Science
• Medical Diagnostics

Background:

• Amyloid diseases involve misfolded protein aggregate accumulation in tissues, complicating diagnosis and treatment.
• These protein aggregations, known as amyloids, are implicated in neurodegenerative conditions like Alzheimer's and Parkinson's diseases.
• Current diagnostic and therapeutic strategies for amyloidosis face significant challenges due to complex protein structures.

Purpose of the Study:

• To utilize Small-Angle X-ray Scattering (SAXS) for examining the supramolecular structures of amyloid aggregates in human tissues.
• To investigate structural changes, specifically axial d-spacing and scattering intensity, in amyloid fibrils across various human tissues.
• To explore the potential of SAXS as a tool for understanding amyloid disorders and developing novel diagnostic and therapeutic approaches.

Main Methods:

• Small-Angle X-ray Scattering (SAXS) was applied directly to thin, intact human tissue samples.
• Analysis focused on momentum transfer values (q) ranging from 0.2 nm⁻¹ to 1.5 nm⁻¹.
• Axial d-spacing and scattering intensity of amyloid fibrils were measured and compared between healthy and amyloid-affected tissues.

Main Results:

• SAXS successfully provided size and shape information of amyloid fibrils, enabling low-resolution 2D model generation.
• Amyloid-laden tissues exhibited prominent axial d-spacing of fibrils (3rd to 10th order) not observed in healthy tissues.
• The axial period of fibrils in amyloid tissues (57.40-64.64 nm⁻¹) differed significantly from normal tissues (60.68-61.41 nm⁻¹), indicating distinct structural characteristics.

Conclusions:

• SAXS is a powerful, non-destructive technique for characterizing amyloid structures directly within human tissues.
• Distinct differences in axial d-spacing observed via SAXS correlate with the presence of amyloid aggregates and disease progression.
• This research highlights SAXS's potential for advancing the understanding of amyloid disorders and developing new diagnostic and therapeutic tools.